Table 4.
Comparison of Clinical Courses and Management Between the Inverted TTC Group and Other Type TTC Group
| Inverted TTC Group (n = 20) | Other Type TTC Group (n = 83) | P | |
|---|---|---|---|
| Use of inotropics, n (%) | 2 (10) | 26 (31) | 0.054 |
| Use of IABP, n (%) | 2 (10) | 10 (12) | 0.798 |
| Use of ACEI or ARB, n (%) | 8 (40) | 49 (59) | 0.124 |
| Use of β‐blocker, n (%) | 6 (30) | 15 (18) | 0.235 |
| Use of diuretic, n (%) | 8 (40) | 32 (39) | 0.905 |
| Temporal pacemaker, n (%) | 2 (10) | 8 (10) | 0.961 |
| ICU hospitalization, n (%) | 12 (60) | 51 (61) | 0.905 |
| ICU hospitalization (d)a | 2.5 (0–8.0) | 2.0 (0–5.0) | 0.938 |
| Hospitalization(d)a | 18.0 (11.0–26.0) | 9.0 (6.0–28.0) | 0.376 |
| In‐hospital cardiac mortality, n(%) | 0 (0) | 0 (0) | — |
| Cardiac mortality during follow‐up, n (%) | 0 (0) | 0 (0) | — |
| Mortality during follow‐up, n (%) | 3 (15) | 9 (11) | 0.603 |
| Recurrence, n (%) | 0 (0) | 0 (0) | — |
Abbreviations: ACEI, angiotensin converting enzyme inhibitor; IABP, intraaortic balloon pump; ARB; angiotensin receptor blocker; ICU, intensive care unit.
Presented as median (interquartile range).